Thirty-five patients with first diagnosed OSA (group 1) and 20 reference patients without OSA (group 2) were prospectively enrolled. Group 1 was divided into 25 patients with starting CPAP therapy (intervention group) and 10 patients without CPAP therapy (control group). PA-TDI interval, measured by tissue Doppler imaging, and B-type natriuretic-peptide (BNP) were determined at baseline and repeated after 30 days in group 1. Patients with OSA had a significantly longer PA-TDI interval (131.4±16.0ms vs. 120.1±6.4ms, p<0.001) compared to reference patients. PA-TDI interval shortened significantly after 30 days of CPAP therapy (131±17.1ms vs. 124.6±15.7ms, p<0.001), whereas no significant change was found in the control group (132.6±13.6ms vs. 133.2±13.1ms, p=0.31) and BNP-levels decreased significantly (39.1±50.7pg/ml vs. 28.2±42.4pg/ml, p<0.01), while BNP-levels remained unaffected after 30 days in control group (31.5±20pg/ml vs. 34.4±20.5pg/ml, p=0.41).
Change in PA-TDI interval, as an indirect surrogate marker of atrial remodelling, suggests reverse atrial remodelling in patients with OSA and treated by CPAP. This effect may ensue from decreased atrial pressure or volume overload, as indicated by significantly reduced BNP levels. These observations suggest that the substrate pre-disposing to AF may be reversible and moreover can be measured by PA-TDI interval and BNP.